News
The baby from Ranaghat in Nadia is suffering from spinal muscular atrophy (SMA) Type I, a condition that causes progressive weakening of the muscles and nerves A 16-month-old girl with a rare genetic ...
Hosted on MSN25d
5K at Xavier University raise awareness for those living with spinal muscular atrophy - MSNCINCINNATI (WKRC) - The annual "Cure SMA Walk-n-Roll" event kicked off Saturday morning at Xavier University, drawing participants to raise awareness and support for those living with spinal ...
Spinal Muscular Atrophy (SMA) is a rare disease affecting the motor nerve cells in the spinal cord. It’s a debilitating condition that affects 1 per 8,000 to 10,000 people worldwide, impacting ...
The 2nd Annual Party With a Purpose to help Andrew Creighton and FightSMA (Spinal Muscular Atrophy) Mechanicsville will be held from 7 to 11:30 p.m. Friday, April 8, at Plant ...
Panelists discuss how spinal muscular atrophy is an autosomal recessive genetic disease affecting motor neurons with 3 ...
New data from Biogen reveals higher Spinraza doses may enhance motor function in SMA patients. Read more here.
Thiruvananthapuram: For the first time in India, pre-symptomatic treatment to an infant, diagnosed with spinal muscular atrophy (SMA) within days of b.
References Borges, B. et al. Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophy. Sci. Transl Med. 17, eadv4656 (2025) ...
Roche’s Evrysdi (risdiplam) tablets have been approved by the European Commission (EC) to treat spinal muscular atrophy (SMA). The new, room-temperature stable formulation of Evrysdi may offer ...
Simplified storage and administration of new tablet formulation may provide greater freedom and independence for people with SMA Evrysdi offers the same efficacy and safety demonstrated in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results